menu
    • menu

    Company profile for Nucleus RadioPharma

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded by Eclipse Ventures and Mayo Clinic, Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new treatment tools.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nucleus RadioPharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Rochester, New York
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nucleusrad.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clarity Inks Deal For Cu-64 Sar-Bispsma Manufacturing
    Clarity Inks Deal For Cu-64 Sar-Bispsma Manufacturing

    14 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/clarity-signs-a-commercial-manufacturing-agreement-for-cu-64-sar-bispsma-with-nucleus-radiopharma-302741108.html

    PR NEWSWIRE
    14 Apr 2026
    Share Share
    Dr. Stephen Hahn Named Ceo of Nucleus Radio Pharma
    Dr. Stephen Hahn Named Ceo of Nucleus Radio Pharma

    20 Aug 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/nucleus-radiopharma-appoints-dr-stephen-hahn-as-ceo/

    CONTRACTPHARMA
    20 Aug 2025
    Share Share
    CDMO Nucleus RadioPharma reveals plan to triple capacity
    CDMO Nucleus RadioPharma reveals plan to triple capacity

    21 Oct 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/radiopharma-cdmo-nucleus-lays-out-plan-boost-manufacturing-will-increase-access

    FIERCE PHARMA
    21 Oct 2024
    Share Share
    Nucleus RadioPharma Expands Capacity For Radiopharmaceuticals
    Nucleus RadioPharma Expands Capacity For Radiopharmaceuticals

    21 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241021820034/en

    BUSINESSWIRE
    21 Oct 2024
    Share Share
    Nucleus RadioPharma: Series A Extension With AstraZeneca Investment
    Nucleus RadioPharma: Series A Extension With AstraZeneca Investment

    05 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240605278093/en

    BUSINESSWIRE
    05 Jun 2024
    Share Share
    AstraZeneca Invests in Nucleus RadioPharma
    AstraZeneca Invests in Nucleus RadioPharma

    05 Jun 2024

    // BIOSPACE

    https://www.biospace.com/article/releases/nucleus-radiopharma-secures-series-a-extension-funding-with-astrazeneca-investment/

    BIOSPACE
    05 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search